Ana Maria Wagner
Overview
Explore the profile of Ana Maria Wagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Alcalde J, Wieland L, Barth J, Grainger R, Baxter N, Heron N, et al.
Int J Med Inform
. 2024 Feb;
184:105345.
PMID: 38309237
Objective: Mobile Health (mHealth) refers to using mobile devices to support health. This study aimed to identify specific methodological challenges in systematic reviews (SRs) of mHealth interventions and to develop...
2.
Perea V, Picon M, Megia A, Goya M, Maria Wagner A, Vega B, et al.
Diabetologia
. 2022 May;
65(8):1302-1314.
PMID: 35546211
Aims/hypothesis: The aim of this study was to assess whether the addition of intermittently scanned continuous glucose monitoring (isCGM) to standard care (self-monitoring of blood glucose [SMBG] alone) improves glycaemic...
3.
Garcia-Perez L, Ramallo-Farina Y, Vallejo-Torres L, Rodriguez-Rodriguez L, Gonzalez-Pacheco H, Santos-Hernandez B, et al.
BMJ Open
. 2022 Apr;
12(4):e058049.
PMID: 35396305
Objective: To analyse the cost-effectiveness of multicomponent interventions designed to improve outcomes in type 2 diabetes mellitus (T2DM) in primary care in the Canary Islands, Spain, within the INDICA randomised...
4.
Ramallo-Farina Y, Rivero-Santana A, Garcia-Perez L, Garcia-Bello M, Maria Wagner A, Gonzalez-Pacheco H, et al.
BMJ Open
. 2021 Dec;
11(12):e050804.
PMID: 34911711
Objective: This study assesses the effectiveness of different interventions of knowledge transfer and behaviour modification to improve type 2 diabetes mellitus patients' (T2DM) reported outcomes measures (PROMs) in the long-term....
5.
Garcia-Delgado Y, Lopez-Madrazo-Hernandez M, Alvarado-Martel D, Miranda-Calderin G, Ugarte-Lopetegui A, Gonzalez-Medina R, et al.
Nutrients
. 2021 Sep;
13(9).
PMID: 34578781
Bariatric surgery is the most efficacious treatment for obesity, though it is not free from complications. Preoperative conditioning has proved beneficial in various clinical contexts, but the evidence is scarce...
6.
Perez-Lopez L, Maria Wagner A, Saavedra P, Jaber J, Melian C
J Feline Med Surg
. 2020 Nov;
23(8):804-808.
PMID: 33236660
Objectives: Adrenal gland size and its association with body weight have been rarely evaluated in cats. This study was undertaken to assess the association between feline body weight and adrenal...
7.
Novoa Y, De La Cuesta A, Caballero E, de Gauna M, Quinteiro S, Dominguez A, et al.
Endocrinol Diabetes Nutr (Engl Ed)
. 2020 Mar;
67(10):658-664.
PMID: 32127309
Aims: To study the incidence of type 1 diabetes (T1D) in children <14 years in the island of Gran Canaria (Canary Islands, Spain) during the 2006-2018 period and to evaluate...
8.
Maria Wagner A, Miranda-Calderin G, Ugarte-Lopetegui M, Marrero-Santiago H, Suarez-Castellano L, Alberiche-Ruano M, et al.
Contemp Clin Trials Commun
. 2018 May;
4:46-51.
PMID: 29736469
Preclinical studies and small clinical trials suggest that glucagon-like peptide 1 (GLP1) may have a positive effect on ventricular function. Liraglutide is a GLP1-analogue used in the treatment of type...
9.
Sanchez-Hernandez R, Prieto-Matos P, Civeira F, Lafuente E, Frias Vargas M, Real J, et al.
Atherosclerosis
. 2017 Dec;
269:1-5.
PMID: 29245109
Background And Aims: Autosomal recessive hypercholesterolemia (ARH) is a very rare disease, caused by mutations in LDL protein receptor adaptor 1 (LDLRAP1). It is characterized by high levels of low-density...
10.
Alberiche M, Sanchez-Hernandez R, Lopez Merida X, Maria Wagner A
Gynecol Endocrinol
. 2016 Nov;
33(1):16-18.
PMID: 27809623
Background: Pregnancy strongly influences the thyroid gland and its function. Thyroid guidelines recommend a 30 to 50% increase of the preconceptional levothyroxine dose in women with hypothyroidism, when pregnancy is...